Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus

PHASE2CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Tinnitus
Interventions
DRUG

AM-101 0.81 mg/mL

DRUG

Placebo

Trial Locations (16)

2650

UZ Antwerp, Department of ENT, Edegem

3500

Virga Jesseziekenhuis Hasselt, Hasselt

9000

Gent University Hospital, Department of ENT, Ghent

27103

PMG Research of Winston-Salem, Winston-Salem

38100

HNO Praxis im Schlosscarree, Braunschweig

40207

Advanced ENT & Allergy, Louisville

51061

HNO Praxis, Cologne

60590

Klinik für Hals-Nasen-Ohrenheilkunde, Kopf- und Halschirurgie, Frankfurt am Main

66160

University of Kansas Medical Center, Kansas City

69126

HNO Gemeinschaftspraxis, Heidelberg

89081

Bundeswehrkrankenhaus Ulm, Ulm

32610-0264

University of Florida College of Medicine, Gainsville

07922

Summit Medical Group, Berkeley Heights

35-055

NZOZ Laryngologii Wojewodzki Szpital Specjalistyczny, Rzeszów

42-600

NZOZ Centrum Medyczne LiMED, Tarnowskie Góry

02-097

Samodzielny Publiczny Centralny Szpital Kliniczny w Warszawie, Warsaw

Sponsors
All Listed Sponsors
lead

Auris Medical, Inc.

INDUSTRY

NCT01270282 - Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus | Biotech Hunter | Biotech Hunter